| Aug 21 |
Dr. Reddy's (RDY), Kainomyx Sign Potential Deal for Malaria Drug
|
| Aug 21 |
Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe
|
| Aug 21 |
J&J (JNJ) Gets FDA Nod for Chemotherapy-Free Lung Cancer Therapy
|
| Aug 20 |
Liquidia (LQDA) Down on FDA Delaying Full Approval for Yutrepia
|
| Aug 20 |
AbbVie (ABBV) Gets Nod in EU for Lymphoma Drug's Expanded Use
|
| Aug 19 |
AN2 Therapeutics (ANTX) Plunges 66% in a Month: Here's Why
|
| Aug 16 |
FDA Expands AstraZeneca's (AZN) Imfinzi Label in Lung Cancer
|
| Aug 9 |
High-Risk, High-Reward: Arcturus Nears Commercialization Of Kostaive Vaccine
|
| Aug 7 |
Arcturus Therapeutics Holdings Second Quarter 2024 Earnings: Beats Expectations
|
| Aug 6 |
Arcturus Therapeutics Holdings Inc. (ARCT) Q2 2024 Earnings Call Transcript
|
